Login to Your Account



Financings Roundup


Monday, March 18, 2013

• Stem Cell Therapeutics Corp., of Toronto, said it closed its prospectus offering of about 12.3 million units priced at C25 cents (US24 cents) each for aggregate gross proceeds of $3.1 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription